Hongchang International Co., Ltd

HCIL ·Healthcare, Medical Devices
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024
Revenue $4.0M $3.5M $3.8M $6.9M $46.4K $820.6K $2.0M $18.2K
Cost of Revenue $3.3M $2.9M $3.2M $5.1M $15.7K $770.5K $1.9M $18.5K
Gross Profit $718.8K $607.1K $613.7K $1.8M $30.7K $50.1K $98.7K $-273
Gross Margin 17.9% 17.5% 16.0% 26.3% 66.3% 6.1% 5.0% -1.5%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $376.9K $352.3K $76.3K $191.9K $234.6K $101.4K $122.6K $102.0K
Operating Income $340.7K $252.2K $537.4K $1.6M $-206.7K $-52.7K $-24.0K $-102.3K
Operating Margin 8.5% 7.3% 14.0% 23.5% -445.5% -6.4% -1.2% -562.0%
Interest Expense — — — — — — — —
Pretax Income $327.5K $241.1K $529.8K $1.7M $-320.1K $-50.2K $-22.4K $-102.0K
Income Tax Expense $23.2K $42.8K $29.8K $152.7K $-10.7K $-5.4K $-733 $-5.4K
Net Income $304.3K $198.2K $499.9K $1.5M $-309.4K $-61.1K $-64.8K $-96.6K
Net Margin 7.6% 5.7% 13.0% 21.8% -666.9% -7.4% -3.3% -530.5%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 518.8M 518.8M 518.8M 518.8M 518.8M 518.8M 518.8M 518.8M
Shares Outstanding (Diluted) 518.8M 518.8M 518.8M 518.8M 518.8M 518.8M 518.8M 518.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 6 Older →